These 4 Measures Indicate That Koninklijke Philips (AMS:PHIA) Is Using Debt Extensively
Jun 23
Dutch (AEX) Healthcare Sector Analysis
UpdatedJul 26, 2024
DataAggregated Company Financials
Companies5
- 7D-0.4%
- 3M21.6%
- 1Y18.4%
- YTD8.5%
Over the last 7 days, the Healthcare industry has remained flat. As for the the longer term, the industry is up 18% over the past 12 months. Earnings are forecast to grow by 48% annually.
Sector Valuation and Performance
Has the Dutch Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jul 2024 | €24.6b | €18.6b | -€848,256,910.67 | 54.1x | -29x | 1.3x |
| Sun, 23 Jun 2024 | €25.0b | €18.6b | -€848,273,715.69 | 51.7x | -29.5x | 1.3x |
| Tue, 21 May 2024 | €26.2b | €18.6b | -€847,311,874.75 | 57.9x | -30.9x | 1.4x |
| Thu, 18 Apr 2024 | €19.7b | €18.6b | -€570,058,570.06 | n/a | -34.6x | 1.1x |
| Sat, 16 Mar 2024 | €20.4b | €18.6b | -€565,049,938.53 | n/a | -36.1x | 1.1x |
| Mon, 12 Feb 2024 | €20.7b | €18.9b | -€725,342,667.17 | n/a | -28.6x | 1.1x |
| Wed, 10 Jan 2024 | €23.9b | €19.3b | -€877,612,905.00 | n/a | -27.2x | 1.2x |
| Fri, 08 Dec 2023 | €20.2b | €19.3b | -€878,001,206.00 | n/a | -23x | 1x |
| Sun, 05 Nov 2023 | €21.0b | €19.3b | -€877,451,863.00 | n/a | -23.9x | 1.1x |
| Tue, 03 Oct 2023 | €20.8b | €19.1b | -€2,302,870,258.00 | n/a | -9x | 1.1x |
| Thu, 31 Aug 2023 | €22.6b | €19.1b | -€2,426,423,239.00 | n/a | -9.3x | 1.2x |
| Sat, 29 Jul 2023 | €21.2b | €19.1b | -€2,437,593,544.00 | n/a | -8.7x | 1.1x |
| Mon, 26 Jun 2023 | €20.9b | €18.8b | -€2,534,891,649.00 | n/a | -8.2x | 1.1x |
| Wed, 24 May 2023 | €20.6b | €18.8b | -€2,532,419,752.00 | n/a | -8.1x | 1.1x |
| Fri, 21 Apr 2023 | €18.4b | €18.5b | -€2,040,623,161.00 | 51.2x | -9x | 1x |
| Sun, 19 Mar 2023 | €17.3b | €18.5b | -€2,026,808,004.00 | 46.9x | -8.5x | 0.9x |
| Tue, 14 Feb 2023 | €17.9b | €18.6b | -€1,793,152,318.00 | 236.2x | -10x | 1x |
| Thu, 12 Jan 2023 | €18.1b | €18.1b | -€1,534,461,988.00 | 267.9x | -11.8x | 1x |
| Sat, 10 Dec 2022 | €15.7b | €18.1b | -€1,540,604,639.00 | 223.2x | -10.2x | 0.9x |
| Mon, 07 Nov 2022 | €15.4b | €18.2b | -€1,534,048,518.00 | 265.7x | -10x | 0.8x |
| Wed, 05 Oct 2022 | €18.9b | €17.9b | €133.7m | 35.2x | 141.5x | 1.1x |
| Fri, 02 Sep 2022 | €19.3b | €17.9b | €229.4m | 36.3x | 84x | 1.1x |
| Sun, 31 Jul 2022 | €22.4b | €17.9b | €171.0m | 45.3x | 131.2x | 1.3x |
| Tue, 28 Jun 2022 | €23.7b | €18.0b | €262.5m | 43x | 90.3x | 1.3x |
| Thu, 26 May 2022 | €25.3b | €18.0b | €261.0m | 44.7x | 97x | 1.4x |
| Sat, 23 Apr 2022 | €29.1b | €17.8b | €485.9m | 38x | 59.8x | 1.6x |
| Mon, 21 Mar 2022 | €29.2b | €17.8b | €484.5m | 38x | 60.3x | 1.6x |
| Wed, 16 Feb 2022 | €30.4b | €17.9b | €414.5m | 35.7x | 73.3x | 1.7x |
| Fri, 14 Jan 2022 | €29.0b | €20.4b | €979.5m | 24.4x | 29.6x | 1.4x |
| Sun, 12 Dec 2021 | €31.0b | €20.4b | €979.5m | 24x | 31.6x | 1.5x |
| Tue, 09 Nov 2021 | €41.7b | €20.4b | €979.5m | 29.4x | 42.6x | 2x |
| Thu, 07 Oct 2021 | €37.4b | €20.7b | €804.3m | 25.9x | 46.5x | 1.8x |
| Sat, 04 Sep 2021 | €40.8b | €20.7b | €808.4m | 28.7x | 50.5x | 2x |
| Mon, 02 Aug 2021 | €40.0b | €20.7b | €808.4m | 29.1x | 49.4x | 1.9x |
Price to Earnings Ratio
49.4x
Current Industry PE
- Investors are relatively neutral on the Dutch Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 3.4% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Dutch Healthcare sector?
| NL Market | -3.90% | |
| Healthcare | -0.37% | |
| Pharma | 8.33% | |
| Biotech | 0.60% | |
| Healthcare Services | 0% | |
| Healthtech | 0% | |
| Life Sciences | 0% | |
| Medical Equipment | -0.50% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 1.7x.
- Analysts are expecting annual earnings decline of 0 so the market might believe that analysts are underestimating future growth.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 63% over the next 5 years.
- In contrast, the Biotech industry is expected to see its earnings decline by 18% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GLPG Galapagos | €25.10 | 1.2% +€19.8m | -31.9% | PE53.9x | |
| BAI BenevolentAI | €0.65 | 8.3% +€6.1m | -52.9% | PS9.1x |